Answers are grounded in this paper and cite their sources.
Purpose: Adaptive optics optical coherence tomography (AO-OCT) has the potential to transform how glaucoma progression is assessed by directly measuring loss of ganglion cells over time. Here, we used AO-OCT to measure ganglion cell layer (GCL) soma loss in glaucoma subjects over time intervals as short as 3 months. Methods: We recruited six glaucoma subjects with moderate-to-severe primary open-angle, low-tension, or pigmentary glaucoma (63.2 ± 3.4 years, mean ± SD) and two age-similar controls. AO-OCT volumes traversing arcuate defects were acquired at both multi-year (2-8 years, 3 subjects) and sub-year (3-12 months, all subjects) intervals. GCL soma count and layer thickness were measured in four to six subregions per subject to determine annualized loss rate (%/yr) across the defect. Clinical OCT thickness measurements were also acquired. Results: Annualized GCL soma loss rates in the 3 multi-year subjects were -1.8, -10.3, and -5.4%/yr, exceeding aging rates in controls by approximately 5 to 28 times. Loss was detectable in all subjects at 3- to 6-month intervals (-0.35 to -7.8%/yr). Soma density loss and GCL thinning rates were weakly correlated when the follow-up interval was under 1 year (glaucomatous: r = 0.32; healthy: r = 0.34). Variation in loss rate across the arcuate defect was significant over sub-year intervals, with the highest rates near the defect edge. Clinical OCT measurements did not exceed progression thresholds in any subject over sub-year intervals. Conclusions: AO-OCT can detect individual glaucomatous GCL soma loss over intervals as short as 3 months, at rates clearly distinguishable from age-related decline. Glaucomatous rates were subclinical by OCT and peaked within the arcuate defect.
No takes yet. Share an insight, caveat, or question.
Keller et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: